Abstract
This haplotype-based case–control study investigated whether the aldosterone synthase gene (CYP11B2) might be implicated in the pathogenesis of essential hypertension in Yi (226 individuals) and Hani (296 individuals) minorities of China. Four tag SNPs (rs4536, rs4545, rs3097, and rs3802230) and the K173R polymorphism were genotyped using the PCR-RFLP method. In the Hani minority, rs4536 was significantly associated with hypertension, after Bonferroni correction. H9 AGGC constructed by tag SNPs was significantly higher in hypertensives than in controls (P = 0.001). Further, we observed that haplotype AGGC remained significantly associated with male hypertension after adjustment for covariates (OR = 3.76, P = 0.002). In the Yi minority, it was found that the CYP11B2 gene was not significantly associated with hypertension. These results indicated that haplotype AGGC conferred an increased risk for hypertension in the Hani minority male. In addition, CYP11B2 may not be associated with hypertension in the Yi minority of China.
Similar content being viewed by others
References
Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, Grimaldi C, Strazzullo P, Cappuccio FP (2004) Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens 22:1895–1901
Brand E, Chatelain N, Keavney B, Caulfield M, Citterio L, Connell J, Grobbee D, Schmidt S, Schunkert H, Schuster H, Sharma AM, Soubrier F (1998) Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 31:725–729
Choh AC, Czerwinski SA, Lee M, Demerath EW, Cole SA, Wilson AF, Towne B, Siervogel RM (2006) Quantitative genetic analysis of blood pressure reactivity to orthostatic tilt using principal components analysis. J Hum Hypertens 20:281–289
Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 5:1513–1522
Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33:703–707
Fardella CE, Rodriguez H, Montero J, Zhang G, Vignolo P, Rojas A, Villarroel L, Miller WL (1996) Genetic variation in P450c11AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab 81:4347–4351
Gu D, Ge D, He J, Li B, Chen J, Liu D, Chen R (2004) Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese. Clin Genet 66:409–416
Halperin E, Kimmel G, Shamir R (2005) Tag SNP selection in genotype data for maximizing SNP prediction accuracy. Bioinformatics 21(Suppl 1):i195–i203
Hengstenberg C, Holmer SR, Mayer B, Lowel H, Engel S, Hense HW, Riegger GA, Schunkert H (2000) Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 35:704–709
Imrie H, Freel M, Mayosi BM, Davies E, Fraser R, Ingram M, Cordell HJ, Farrall M, Avery PJ, Watkins H, Keavney B, Connell JM (2006) Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. J Clin Endocrinol Metab 91:5051–5056
Isaji M, Mune T, Takada N, Yamamoto Y, Suwa T, Morita H, Takeda J, White PC (2005) Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2. J Hypertens 23:1149–1157
Iwai N, Kajimoto K, Tomoike H, Takashima N (2007) Polymorphism of CYP11B2 determines salt sensitivity in Japanese. Hypertension 49:825–831
Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T, Sato T, Yamori Y, Yazaki Y (2000) Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 18:1025–1032
Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Nishimori T, Takasu N (2000) Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 35:699–703
Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ (2003) Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens 21:1331–1337
Lifton RP, Gharavi AG, Geller DS (2001) Molecular mechanisms of human hypertension. Cell 104:545–556
Lim PO, Macdonald TM, Holloway C, Friel E, Anderson NH, Dow E, Jung RT, Davies E, Fraser R, Connell JM (2002) Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 87:4398–4402
Luft FC (2001) Twins in cardiovascular genetic research. Hypertension 37:350–356
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Mitsuuchi Y, Kawamoto T, Naiki Y, Miyahara K, Toda K, Kuribayashi I, Orii T, Yasuda K, Miura K, Nakao K, Imura H, Ulick S, Shizuta Y (1992) Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450C18 gene (CYP11B2) in CMO II deficient patients. Biochem Biophys Res Commun 182:974–979
Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P (2003) A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 88:2495–2500
Qi Y, Niu W, Zhu T, Zhou W, Qiu C (2008) Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol 23:143–152
Rajput C, Makhijani K, Norboo T, Afrin F, Sharma M, Pasha ST, Pasha MA (2005) CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake. J Hypertens 23:79–86
Rajput C, Arif E, Vibhuti A, Stobdan T, Khan AP, Norboo T, Afrin F, Qadar Pasha MA (2006) Predominance of interaction among wild-type alleles of CYP11B2 in Himalayan natives associates with high-altitude adaptation. Biochem Biophys Res Commun 348:735–740
Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97–98
Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G (2001) Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19:1349–1358
Stella P, Bigatti G, Tizzoni L, Barlassina C, Lanzani C, Bianchi G, Cusi D (2004) Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J Am Coll Cardiol 43:265–270
Tamaki S, Iwai N, Tsujita Y, Kinoshita M (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 33:266–270
Tang W, Wu H, Zhou X, Cheng B, Dong Y, He L, Yu H, Xu L, Lu J, Li K, Xiao C (2006) Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China. Clin Chim Acta 364:222–225
Tanira MO, Al Balushi KA (2005) Genetic variations related to hypertension: a review. J Hum Hypertens 19:7–19
Taymans SE, Pack S, Pak E, Torpy DJ, Zhuang Z, Stratakis CA (1998) Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J Clin Endocrinol Metab 83:1033–1036
Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J, Baba S (2001) Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res 24:105–109
Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H, Ohta S, Akashi M, Minami J, Ono H, Ohrui M, Matsuoka H (2002) Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens 16:789–793
White PC, Slutsker L (1995) Haplotype analysis of CYP11B2. Endocr Res 21:437–442
Xu XJ, Wang SZ, Lin RY, Wang XF, Liang XH, Wen H, Zhang ZX (2004) Association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated group. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21:622–624
Zhang K, Calabrese P, Nordborg M, Sun F (2002) Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 71:1386–1394
Zhang K, Qin ZS, Liu JS, Chen T, Waterman MS, Sun F (2004) Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res 14:908–916
Acknowledgments
This work was financially supported by the National Nature Science Foundation of China (No. U0932603, 3091112048) and the Natural Science Foundation of Yunnan Province (No. 2009CC001).
Author information
Authors and Affiliations
Corresponding author
Additional information
Bifeng Chen and Shengjie Nie contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, B., Nie, S., Yue, Z. et al. Haplotype-Based Case–Control Study of the Human CYP11B2 Gene and Essential Hypertension in Yi and Hani Minorities of China. Biochem Genet 49, 122–137 (2011). https://doi.org/10.1007/s10528-010-9393-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-010-9393-5